Karuna Therapeutics Inc
:KRTX 4:00:00 PM EDT
Market Cap (Intraday) | NA |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $325.17 |
50-Day MA | $317.94 |
200-Day MA | $229.33 |
Karuna Therapeutics Inc Stock, :KRTX
99 High Street, 26th floor, Boston, Massachusetts 02110
United States of America
Phone: +1.857.449.2244
Number of Employees: 339
Description
Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological and psychiatric illnesses, with a particular focus on schizophrenia and the behavioral symptoms of Alzheimer's disease. The company is skilled in neuroscience and has creative ideas for finding and developing new drugs. Karuna Therapeutics is� advancing a pipeline of innovative drugs since its inception with the aim of significantly improving the lives of people suffering from these difficult conditions.